Trials / Conditions / Vector Borne Diseases

Vector Borne Diseases

9 registered clinical trials studyying Vector Borne Diseases — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines NCT05978037	University of Oxford	Phase 1 / Phase 2
Completed	Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falci NCT05979207	Medicines for Malaria Venture	Phase 1
Active Not Recruiting	A Study to Compare Two Dosing Regimens for a New Malaria Vaccine NCT06141057	University of Oxford	Phase 1
Completed	Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities NCT06179732	The Mentor Initiative	Phase 3
Completed	Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia NCT04434846	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy NCT06917040	The Mentor Initiative	Phase 3
Completed	Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-endemic Participants in Cambodia NCT04350905	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Recruiting	Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing NCT04034264	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating NCT06268691	Rocio Cardenas Sanchez	N/A